1,724
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Prognostic value of lactate dehydrogenase, serum albumin and the lactate dehydrogenase/albumin ratio in patients with diffuse large B-cell lymphoma

, , , , , , , , & show all
Article: 2293514 | Received 16 Jul 2023, Accepted 05 Dec 2023, Published online: 18 Dec 2023

References

  • Martelli M, Ferreri AJ, Agostinelli C, et al. Diffuse large B-cell lymphoma. Crit Rev Oncol Hematol. 2013;87(2):146–171. doi:10.1016/j.critrevonc.2012.12.009
  • Wang L, Li LR. R-CHOP resistance in diffuse large B-cell lymphoma: biological and molecular mechanisms. Chin Med J. 2020;134(3):253–260. doi:10.1097/CM9.0000000000001294
  • International Non-Hodgkin’s Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin’s lymphoma. N Engl J Med. 1993;329(14):987–994.
  • Ghesquieres H, Slager SL, Jardin F, et al. Genome-wide association study of event-free survival in diffuse large B-cell lymphoma treated with immunochemotherapy. J Clin Oncol: Official J Am Soc Clin Oncol. 2015;33(33):3930–3937. doi:10.1200/JCO.2014.60.2573
  • Schmitz R, Wright GW, Huang DW, et al. Genetics and pathogenesis of diffuse large B-cell lymphoma. N Engl J Med. 2018;378(15):1396–1407. doi:10.1056/NEJMoa1801445
  • Infusino I, Panteghini M. Serum albumin: accuracy and clinical use. Clin Chim Acta. 2013;419:15–18. doi:10.1016/j.cca.2013.01.005
  • Turcato G, Zaboli A, Sibilio S, et al. Prognostic role of serum albumin in predicting 30-day mortality in patients with infections in emergency department: a prospective study. J Clin Med. 2023;12(10):3447, doi:10.3390/jcm12103447
  • Spassov B, Vassileva D, Mihaylov G, et al. Serum albumin and peripheral blood neutrophils at diagnosis may provide additional prognostic information in primary nodal diffuse large-B-cell lymphoma patients treated with R-CHOP. Blood. 2016;128(22):5304, doi:10.1182/blood.V128.22.5304.5304
  • Wei Y, Wei X, Huang W, et al. Albumin improves stratification in the low IPI risk patients with diffuse large B-cell lymphoma. Int J Hematol. 2020;111(5):681–685. doi:10.1007/s12185-020-02818-9
  • Ding J, Karp JE, Emadi A. Elevated lactate dehydrogenase (LDH) can be a marker of immune suppression in cancer: interplay between hematologic and solid neoplastic clones and their microenvironments. Cancer Biomarkers: Sect A of Dis Markers. 2017;19(4):353–363.
  • Huang H, Fan L, Fu D, et al. Clinical characteristics and outcomes of patients with diffuse large B cell lymphoma treated with R-CHOP-like or CHOP-like regimens: an 8-year experience from a single center. Ann Palliat Med. 2020;9(4):1442–1452. doi:10.21037/apm-19-589
  • Gao F, Wang ZF, Tian L, et al. A prognostic model of gastrointestinal diffuse large B cell lymphoma. Med Sci Monit. 2021;27(E929898-1–E929898-13). Published 2021 Aug 27.
  • Zhang Y, Chen Q, Lu C, et al. Prognostic role of controlling nutritional status score in hematological malignancies. Hematology. 2022;27(1):653–658. doi:10.1080/16078454.2022.2078040
  • Jung SH, Yang DH, Ahn JS, et al. Serum lactate dehydrogenase with a systemic inflammation score is useful for predicting response and survival in patients with newly diagnosed diffuse large B-cell lymphoma. Acta Haematol. 2015;133(1):10–17. doi:10.1159/000360068
  • Aday U, Böyük A, Akkoç H. The prognostic significance of serum lactate dehydrogenase-to-albumin ratio in colorectal cancer. Ann Surg Treat Res. 2020;99(3):161–170. doi:10.4174/astr.2020.99.3.161
  • Aday U, Tatlı F, Akpulat FV, et al. Prognostic significance of pretreatment serum lactate dehydrogenase-to-albumin ratio in gastric cancer. Contemp Oncol (Pozn). 2020;24(3):145–149.
  • He J, Tong L, Wu P, et al. Prognostic significance of preoperative lactate dehydrogenase to albumin ratio in breast cancer: a retrospective study. Int J Gen Med. 2023;16:507–514. doi:10.2147/IJGM.S396871
  • Mao L, Wang X, Wang CY, et al. Evaluation of different staging systems and prognostic analysis of 110 primary gastrointestinal diffuse large B cell lymphoma. Zhonghua Yi Xue Za Zhi. 2019;99(24):1853–1858.
  • Hu X, Feng X, Wang H, et al. Association between serum albumin levels and survival in elderly patients with diffuse large B-cell lymphoma: a single-center retrospective study. Transl Cancer Res. 2023;12(6):1577–1587. doi:10.21037/tcr-23-503
  • Wei X, Zheng J, Zhang Z, et al. Consecutive hypoalbuminemia predicts inferior outcome in patients with diffuse large B-cell lymphoma. Front Oncol. 2021;10:610681, doi:10.3389/fonc.2020.610681
  • Bakirtas M, Basci S, Candır BA, et al. Prognostic value of neutrophil/lymphocyte ratio, lymphocyte/monocyte ratio, lactate dehydrogenase, and mean platelet volume in the diagnosis of patients with diffuse large B-cell lymphoma. Egypt J Haematology. 2022;47(4):233–238.
  • Tyagi A, Abrari A, Khurana A, et al. Immunohistochemical subtyping of diffuse large B-cell lymphoma into germinal center B-cell and activated B-cell subtype, along with correlation of the subtypes with extranodal involvement, serum lactate dehydrogenase, and positron emission tomography scan-based response assessment to chemotherapy. J Cancer Res Ther. 2022;18(4):1129–1136. doi:10.4103/jcrt.JCRT_842_20
  • Tessari P. Protein metabolism in liver cirrhosis: from albumin to muscle myofibrils. Curr Opin Clin Nutr Metab Care. 2003;6(1):79–85. doi:10.1097/00075197-200301000-00012
  • Fanali G, di Masi A, Trezza V, et al. Human serum albumin: from bench to bedside. Mol Asp Med. 2012;33(3):209–290. doi:10.1016/j.mam.2011.12.002
  • Ghuman J, Zunszain PA, Petitpas I, et al. Structural basis of the drug-binding specificity of human serum albumin. J Mol Biol. 2005;353(1):38–52. doi:10.1016/j.jmb.2005.07.075
  • Kaneko H, Shimura K, Yoshida M, et al. Serum albumin levels strongly predict survival outcome of elderly patients with diffuse large B-cell lymphoma treated with rituximab-combined chemotherapy. Int J Hematol Oncol Stem Cell Res. 2022;16(1):1–8.
  • Guo Y, Wei L, Patel SH, et al. Serum albumin: early prognostic marker of benefit for immune checkpoint inhibitor monotherapy but not chemoimmunotherapy. Clin Lung Cancer. 2022;23(4):345–355. doi:10.1016/j.cllc.2021.12.010
  • de la Cruz-López KG, Castro-Muñoz LJ, Reyes-Hernández DO, et al. Lactate in the regulation of tumor microenvironment and therapeutic approaches. Front Oncol. 2019;9:1143, Published 2019 Nov 1.
  • García R, Hernández JM, Caballero MD, et al. Serum lactate dehydrogenase level as a prognostic factor in Hodgkin’s disease. Br J Cancer. 1993;68(6):1227–1231. doi:10.1038/bjc.1993.509
  • Michot JM, Benajiba L, Faivre L, et al. Outcomes and prognostic factors for relapsed or refractory lymphoma patients in phase I clinical trials. Invest New Drugs. 2018;36(1):62–74. doi:10.1007/s10637-017-0480-x
  • Xie Z, Zhou H, Wang L, et al. The Significance of the preoperative lactate dehydrogenase/albumin ratio in the prognosis of colon cancer: a retrospective study. Peer J. 2022;10:e13091, doi:10.7717/peerj.13091
  • Hu Y, Zhou Y, Cao Y, et al. Nomograms based on lactate dehydrogenase to albumin ratio for predicting survival in colorectal cancer. Int J Med Sci. 2022;19(6):1003–1012. doi:10.7150/ijms.71971
  • Feng JF, Wang L, Yang X, et al. Prognostic value of lactate dehydrogenase to albumin ratio (LAR) in patients with resectable esophageal squamous cell carcinoma. Cancer Manag Res. 2019;11:7243–7251. doi:10.2147/CMAR.S208320
  • Ni T, Wen Y, Wang Y, et al. Association between albumin or prealbumin levels at different stages and prognosis in severe acute pancreatitis: a 5-year retrospective study. Sci Rep. 2022;12(1):16792, doi:10.1038/s41598-022-21278-1
  • Gilreath JA, Stenehjem DD, Rodgers GM. Diagnosis and treatment of cancer-related anemia. Am J Hematol. 2014;89(2):203–212. doi:10.1002/ajh.23628
  • Kamei A, Gao G, Neale G, et al. Exogenous remodeling of lung resident macrophages protects against infectious consequences of bone marrow-suppressive chemotherapy. Proc Natl Acad Sci USA. 2016;113(41):E6153–E6161.
  • Aapro M, Jelkmann W, Constantinescu SN, et al. Effects of erythropoietin receptors and erythropoiesis-stimulating agents on disease progression in cancer. Br J Cancer. 2012;106(7):1249–1258. doi:10.1038/bjc.2012.42
  • Matsumoto K, Fujisawa S, Ando T, et al. Anemia associated with worse outcome in diffuse large B-cell lymphoma patients: a single-center retrospective study. Turkish J Haematology: Official J Turkish Soc Haematology. 2018;35(3):181–184.